Prophylactic administration of carnosine and melatonin abates the incidence of renal toxicity induced by an over dose of titanium dioxide nanoparticles

Journal of Biochemical and Molecular Toxicology
Laila Mohamed FaddaManal Aldossari

Abstract

The alleviative effects of two antioxidants, carnosine (Car) and melatonin (Mel), against titanium dioxide nanoparticles (TiO2 -NPs) toxicity-induced oxidative and inflammatory renal damage were examined in rats. Administration of these antioxidants along with TiO2 -NPs effectively reduced serum urea, uric acid, creatinine, glucose, tumor necrosis factor-α, interleukin-6, C-reactive protein, immunoglobulin G, vascular endothelial growth factor, and nitric oxide, as well as a significant amelioration of the decrease in glutathione levels in renal tissue was observed, compared to those in rats treated with TiO2 -NPs alone. The renoprotective properties of the antioxidants were confirmed by reduced intensity of renal damage as demonstrated by histological findings. In conclusion, Car and Mel play protective roles against TiO2 -NPs-induced renal inflammation and oxidative injury, likely due to their antioxidant and anti-inflammatory properties.

References

Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
Jan 1, 1997·Free Radical Biology & Medicine·Z MatuszakC F Chignell
Jan 27, 1999·Biochemical and Biophysical Research Communications·D X TanA M Shepherd
May 20, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Ozlem U GurkanPatrice M Becker
Oct 4, 2006·Journal of Pineal Research·Emanuela MazzonSalvatore Cuzzocrea
Aug 1, 2007·Nephron. Clinical Practice·Mohamed-Saiel Saeed AlhamdaniMaha F Al-Taee
Aug 5, 2008·Colloids and Surfaces. B, Biointerfaces·Stephanie VelezV Prakash Reddy
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zheng WangZhao-You Tang
Dec 11, 2008·Biological Trace Element Research·Huiting LiuFashui Hong
Nov 26, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Radu IliescuAlejandro R Chade
May 8, 2010·Journal of Pineal Research·Shi-Young ParkYung-Jin Kim
Jul 1, 2010·Circulation. Cardiovascular Interventions·Alejandro R Chade, Silvia Kelsen
Sep 8, 2010·Experimental Gerontology·Sara CuestaJesús A F Tresguerres
Oct 12, 2010·Journal of Agricultural and Food Chemistry·Shih-Jei TsaiMei-Chin Yin
Oct 23, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Liang XiGary F Lewis
Nov 26, 2010·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Ritesh K ShuklaAlok Dhawan
Jun 23, 2011·European Journal of Pharmacology·Xiangmin ZhangZhan Zhang
May 1, 2008·Environmental Toxicology and Pharmacology·Amr A FouadWafaey Gomaa
Sep 13, 2011·Journal of Hazardous Materials·Suxing GuiFashui Hong
Jan 21, 2012·The Journal of Surgical Research·Zeki Ilker KunakLevent Kenar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here